BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9214409)

  • 1. Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection.
    Sarac E; Bastacky S; Johnson JP
    Am J Kidney Dis; 1997 Jul; 30(1):113-5. PubMed ID: 9214409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha.
    Yamabe H; Johnson RJ; Gretch DR; Osawa H; Inuma H; Sasaki T; Kaizuka M; Tamura N; Tsunoda S; Fujita Y
    Am J Kidney Dis; 1995 Jan; 25(1):67-9. PubMed ID: 7810536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked.
    Bandi L
    Postgrad Med; 2003 Feb; 113(2):73-6, 86. PubMed ID: 12611116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
    Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
    Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus.
    Lopes EP; Valente LM; Silva AE; Kirsztajn GM; Cruz CN; Ferraz ML
    Braz J Infect Dis; 2003 Oct; 7(5):353-7. PubMed ID: 14552746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
    Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
    Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
    Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
    Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.
    Namba T; Shiba R; Yamamoto T; Hirai Y; Moriwaki T; Matsuda J; Kadoya H; Takeji M; Yamada Y; Yoshihara H; Yamauchi A
    Clin Exp Nephrol; 2010 Aug; 14(4):372-6. PubMed ID: 20467773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of membranoproliferative glomerulonephritis due to type II cryoglobulinemia probably associated with hepatitis C virus infection].
    Ikeda Y; Nakano H; Sakemi T; Nagano Y; Otsuka N; Baba N; Syouno Y; Yamaguchi K
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):284-8. PubMed ID: 8196226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection].
    Guarnieri A; Marazzi F; Giorgi MP; Canepari G; Pino C; Moggia E; Manca A; Ghezzi PM
    G Ital Nefrol; 2002; 19(1):79-81. PubMed ID: 12165950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive renal failure and blindness due to retinal hemorrhage after interferon therapy for hepatitis C virus-associated membranoproliferative glomerulonephritis.
    Suzuki T; Yonemura K; Miyaji T; Suzuki H; Takahira R; Fujigaki Y; Fujimoto T; Hishida A
    Intern Med; 2001 Aug; 40(8):708-12. PubMed ID: 11518107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
    Elmowafy AY; El Maghrabi HM; Zahab MA; Elwasif SM; Bakr MA
    Iran J Kidney Dis; 2018 Nov; 12(6):382-384. PubMed ID: 30595569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Cryoglobulinemic Membranoproliferative Glomerulonephritis Induced by Hepatitis C Virus.
    Otsuka T; Sakai Y; Ohno D; Tsuruoka S
    J Nippon Med Sch; 2015; 82(4):193-201. PubMed ID: 26328796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
    Shimada M; Nakamura N; Endo T; Yamabe H; Nakamura M; Murakami R; Narita I; Tomita H
    BMC Nephrol; 2017 Mar; 18(1):109. PubMed ID: 28356063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus associated glomerulopathies.
    Ozkok A; Yildiz A
    World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pegylated interferon alpha-2a on hepatitis-C-virus-associated glomerulonephritis.
    Sugiura T; Yamada T; Kimpara Y; Fujita N; Goto K; Koyama N
    Pediatr Nephrol; 2009 Jan; 24(1):199-202. PubMed ID: 18696119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon therapy in cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection].
    Mátyus J; Kovács J; Ujhelyi L; Kárpáti I; Dalmi L; Kakuk G
    Orv Hetil; 1996 Nov; 137(45):2527-30. PubMed ID: 8999399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.